Magnetic tracer trial aims to sharpen stomach cancer surgery
NCT ID NCT05038098
Summary
This early-stage study is testing the safety and feasibility of a new magnetic tracer, FerroTrace, used alongside a fluorescent dye to help surgeons better identify the lymph nodes most likely to contain cancer during stomach removal surgery. The goal is to improve the accuracy of cancer staging, which guides treatment decisions. The study will enroll about 20 adults with localized stomach cancer who are scheduled for curative surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.